MEDIWOUND LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.22 USD | +5.37% |
|
+21.95% | +88.99% |
| 21/03 | MediWound Ltd. Provides Revenue Guidance for the Year 2025 and 2026 | CI |
| 21/03 | Transcript : MediWound Ltd., Q4 2023 Earnings Call, Mar 21, 2024 |
Chart calendar MediWound Ltd.
251d54771784a77456.sTlCIlvhx8d7eneO8KWQTaF-gQPzaN7zIUIeYjZOcmU.-HUvdS_VqvcREEb-o8akOJYhxHe2AYu7QDt8BnMtFDXUXnNxE9i3hB1PEA~414e80717e846214a1e81a934bf395bb
Upcoming events on MediWound Ltd.
Past events on MediWound Ltd.
| 21/03/2024 06:00 pm | Q4 2023 Earnings Call |
| 21/03/2024 04:30 pm | Q4 2023 Earnings Release |
| 04/03/2024 09:40 pm | TD Cowen Health Care Conference |
| 13/02/2024 07:10 pm | Oppenheimer Healthcare Life Sciences Conference |
| 08/01/2024 | LifeSci Partners Corporate Access Event |
| 28/11/2023 | Advanced Wound Care Europe Conference |
| 21/11/2023 07:00 pm | Q3 2023 Earnings Call |
| 21/11/2023 05:32 pm | Q3 2023 Earnings Release |
| 13/09/2023 11:00 pm | H.C. Wainwright Global Investment Conference |
| 06/09/2023 | European Burns Association Congress |
| 16/08/2023 06:00 pm | Q2 2023 Earnings Call |
| 16/08/2023 01:33 am | Q2 2023 Earnings Release |
| 20/06/2023 07:00 pm | Maxim Group Virtual Healthcare Conference |
| 30/05/2023 06:00 pm | Q1 2023 Earnings Call |
| 30/05/2023 04:30 pm | Q1 2023 Earnings Release |
| 16/03/2023 06:00 pm | Q4 2022 Earnings Call |
| 16/03/2023 04:40 pm | Q4 2022 Earnings Release |
| 14/03/2023 10:50 pm | Oppenheimer Healthcare Conference |
| 08/03/2023 09:00 pm | Cowen Health Care Conference |
| 15/11/2022 07:00 pm | Q3 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 31,8 30,4 4.48% | 21,8 20,7 5.18% | 23,8 23,9 -0.37% | 26,5 21,5 23.04% | 18,7 18,7 0.13% | 24,0 |
|
EBITDA Million USD | Released Forecast Spread | 8,05 6,80 18.35% | -6,43 0,00 - | -8,31 -8,00 -3.88% | -4,44 -8,30 46.47% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 4,49 5,28 -14.89% | -8,84 -8,74 -1.16% | -11,2 -10,5 -7.31% | -8,35 -12,6 33.56% | -15,3 -13,7 -11.93% | -18,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2,07 3,16 -34.55% | -9,20 -11,0 16.58% | -13,5 -13,4 -0.8% | -19,5 -13,8 -41.47% | -6,53 -7,07 7.61% | -17,9 |
|
Net income Million USD | Released Forecast Spread | 4,96 5,52 -10.16% | -9,20 -10,5 12.55% | -13,6 -13,4 -0.98% | -19,6 -16,8 -16.87% | -6,72 -6,61 -1.62% | -17,8 |
|
EPS USD | Released Forecast Spread | 1,26 1,43 -11.76% | -2,38 -2,73 12.82% | -3,50 -3,43 -2.04% | -3,93 -2,17 -81.38% | -0,75 -0,80 5.96% | -1,93 |
| Announcement Date | 25/02/20 | 25/02/21 | 17/03/22 | 16/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,49 5,54 -0.88% | 4,41 4,29 2.64% | 4,67 5,28 -11.53% | 5,80 4,60 26.08% | 11,6 6,60 76.02% | 3,80 5,15 -26.23% | 4,77 4,18 14.19% | 4,78 4,75 0.65% | 5,34 5,33 0.23% | 4,67 | 5,38 | 6,23 | 7,76 | 6,64 |
|
EBIT Million USD | Released Forecast Spread | -3,52 -3,45 -2.18% | -3,28 -2,86 -14.65% | -3,67 -2,57 -43.14% | -3,51 -2,98 -17.95% | 2,12 -2,13 199.51% | -4,36 -2,00 -118.05% | -4,01 -3,68 -8.79% | -3,03 -3,89 22.18% | -3,89 -2,26 -72.07% | -4,17 | -4,29 | -4,78 | -5,53 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,16 -4,04 -2.93% | -3,59 -3,90 7.98% | -4,35 -3,09 -40.72% | -4,19 -3,36 -24.82% | -7,39 -1,75 -323.29% | -3,69 -4,65 20.75% | 0,93 -4,04 122.99% | -2,15 -4,24 49.31% | -1,62 -2,14 24.09% | -3,77 | -3,92 | -4,45 | -5,53 | |
|
Net income Million USD | Released Forecast Spread | -4,16 -4,02 -3.42% | -3,59 -3,30 -8.7% | -4,35 -2,97 -46.36% | -4,20 -3,36 -24.97% | -7,46 -4,69 -59.11% | -3,69 -1,05 -252.22% | 0,92 -3,89 123.57% | -2,20 -3,89 43.51% | -1,74 -1,63 -7.13% | -3,65 | -3,94 | -4,37 | -5,58 | |
|
EPS USD | Released Forecast Spread | -1,05 -1,05 0% | -0,84 -0,81 -4.35% | -0,91 -0,68 -34.48% | -0,91 -0,69 -32.65% | -1,18 -0,59 -98.88% | -0,44 -0,18 -144.44% | 0,10 -0,37 126.79% | -0,24 -0,40 40% | -0,19 -0,23 16.48% | -0,41 | -0,43 | -0,48 | -0,60 | -0,65 |
| Announcement Date | 17/03/22 | 17/05/22 | 09/08/22 | 15/11/22 | 16/03/23 | 30/05/23 | 15/08/23 | 21/11/23 | 21/03/24 | - | - | - | - | - |
| Today 04:30 pm | INCYTE CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
| 02/05/2024 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
| 06/05/2024 04:30 pm | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | BIOTEST AG: Q1 2024 Earnings Release |
| 07/05/2024 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | REVANCE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 11:30 am | BIOGAIA AB: Q1 2024 Earnings Release |
Past sector events for MediWound Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MDWD Stock
- Calendar MediWound Ltd.
